These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 36923882

  • 21. Luteolin transforms the polarity of bone marrow-derived macrophages to regulate the cytokine storm.
    Wang S, Xu S, Zhou J, Zhang L, Mao X, Yao X, Liu C.
    J Inflamm (Lond); 2021 May 31; 18(1):21. PubMed ID: 34059076
    [Abstract] [Full Text] [Related]

  • 22. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.
    Zheng C, Wang Y, Xu Y, Zhou L, Hassan S, Xu G, Zou X, Zhang M.
    Int Immunopharmacol; 2021 Dec 31; 101(Pt A):108329. PubMed ID: 34749293
    [Abstract] [Full Text] [Related]

  • 23. Luteolin Alters Macrophage Polarization to Inhibit Inflammation.
    Wang S, Cao M, Xu S, Shi J, Mao X, Yao X, Liu C.
    Inflammation; 2020 Feb 31; 43(1):95-108. PubMed ID: 31673976
    [Abstract] [Full Text] [Related]

  • 24. IRF4 induces M1 macrophage polarization and aggravates ulcerative colitis progression by the Bcl6-dependent STAT3 pathway.
    Wang J, Wu Z, Huang Y, Jin L, Xu J, Yao Z, Ouyang X, Zhou Z, Mao S, Cao J, Lai B, Shen W.
    Environ Toxicol; 2024 Apr 31; 39(4):2390-2404. PubMed ID: 38164749
    [Abstract] [Full Text] [Related]

  • 25. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation.
    Li C, Xi Y, Li S, Zhao Q, Cheng W, Wang Z, Zhong J, Niu X, Chen G.
    Mol Immunol; 2015 Oct 31; 67(2 Pt B):444-54. PubMed ID: 26224047
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. LncRNA MIR4435-2HG suppression regulates macrophage M1/M2 polarization and reduces intestinal inflammation in mice with ulcerative colitis.
    Cao L, Tan Q, Zhu R, Ye L, Shi G, Yuan Z.
    Cytokine; 2023 Oct 31; 170():156338. PubMed ID: 37597495
    [Abstract] [Full Text] [Related]

  • 31. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J, Wu Z, Zhao Z, Wu C, Yuan M, Su Z, Wang Y, Wang Z.
    Int J Nanomedicine; 2020 Oct 31; 15():3937-3951. PubMed ID: 32581538
    [Abstract] [Full Text] [Related]

  • 32. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism.
    Sun X, Zhang Y, Cheng G, Zhu T, Zhang Z, Xiong L, Hu H, Liu H.
    Biomed Pharmacother; 2023 Nov 31; 167():115430. PubMed ID: 37683590
    [Abstract] [Full Text] [Related]

  • 33. M2 Macrophage-Derived Exosomal miR-590-3p Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via the LATS1/YAP/ β-Catenin Signalling Axis.
    Deng F, Yan J, Lu J, Luo M, Xia P, Liu S, Wang X, Zhi F, Liu D.
    J Crohns Colitis; 2021 Apr 06; 15(4):665-677. PubMed ID: 33075119
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lycium barbarum polysaccharide alleviates dextran sodium sulfate-induced inflammatory bowel disease by regulating M1/M2 macrophage polarization via the STAT1 and STAT6 pathways.
    Wang J, Gao H, Xie Y, Wang P, Li Y, Zhao J, Wang C, Ma X, Wang Y, Mao Q, Xia H.
    Front Pharmacol; 2023 Apr 06; 14():1044576. PubMed ID: 37144216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.